MAT

Quit Genius Selected for Evernorth Digital Health Formulary to Provide Alcohol and Opioid Use Disorder Care

Retrieved on: 
Thursday, September 15, 2022
Nicotine, Opioid addiction treatment in United States prisons, Opioid use disorder, Formulary, COVID, Program, Mental health, Patient, CEO, Liver failure, Evidence-based practice, Â, Solution, Tobacco, Workplace, MAT, Randomized controlled trial, Digital health, Pharmacy, GLOBE, Health insurance, Pharmaceutical industry

These solutions are in addition to Quit Genius tobacco use disorder care solution, which was added to the Formulary in 2019, and rounds out a suite of substance use disorder care.

Key Points: 
  • These solutions are in addition to Quit Genius tobacco use disorder care solution, which was added to the Formulary in 2019, and rounds out a suite of substance use disorder care.
  • Weve expanded our digital clinic to offer solutions for tobacco, alcohol and opioid addictions, as we strongly believe employers and health payers need an end-to-end solution for multiple addictions focused on the continuum of addiction care.
  • To meet this urgent need and give employers an affordable healthcare benefit that provides broader access and better care for employees, Quit Genius now offers care for alcohol and opioid addictions.
  • Quit Genius is the worlds first digital clinic for treating nicotine, alcohol and opioid addictions.

Pathway Healthcare expands with Innovation360 in Texas

Retrieved on: 
Monday, September 12, 2022
Managed Care, Health, Mental Health, People, IOP, Love, Organizational culture, COVID-19, Psychiatry, PHP, Population, Acquisition, Health, COO, Topical steroid withdrawal, Program, Patient, Mental health, CEO, Adolescence, Pathway, MAT, Transport, Anxiety, Counselor, Health care, Translation, Depression, Housing, Pharmaceutical industry, Medicine

Pathway Healthcare, now with 18 outpatient locations across 6 states, is pleased to announce the acquisition of Innovation360, based in Dallas, Texas.

Key Points: 
  • Pathway Healthcare, now with 18 outpatient locations across 6 states, is pleased to announce the acquisition of Innovation360, based in Dallas, Texas.
  • From the CEO of Pathway Healthcare: I am so grateful to partner with my friend Kevin Gilliland and his incredible team.
  • Welcoming Innovation360 to the Pathway family has been seamless; our cultures of Helping People and serving our patients with integrity and love are completely aligned.
  • Pathway Healthcare provides in-network, outpatient care for mental health, addiction, and alcohol or medication dependency.

AdCare Rhode Island Named Fastest Growing Companies Finalist by Providence Business News

Retrieved on: 
Friday, September 9, 2022
COO, American Addiction Centers, CEO, Bed, MAT, RI, Anxiety, Depression, GLOBE, Â, Adcare Hospital, Growth, COVID, Telehealth, Patient, Hospital

“More patients entering the inpatient detox and residential program at AdCare Rhode Island -- the only residential facility in the state to initiate patients on medication assisted therapies -- opted to begin MAT and experienced an overall success rate of 82%,” said Trapassi.

Key Points: 
  • NORTH KINGSTOWN, R.I., Sept. 09, 2022 (GLOBE NEWSWIRE) -- AdCare Rhode Island is excited to be recognized for the second consecutive year as a Providence Business News Fastest Growing Companies finalist in the $5 million to $25 million category.
  • In our communities, the state of Rhode Island, and across the country, the opioid/fentanyl overdose epidemic worsened by COVID is unlike anything weve ever seen, said Trapassi.
  • Since its purchase in 2018 by American Addiction Centers , a national provider of addiction treatment, AdCare Rhode Islands inpatient, outpatient and telehealth services have grown to provide the most comprehensive continuum of substance use disorder treatment in Rhode Island.
  • To learn more about treatment at the AdCare Rhode Islands inpatient program, please call 401-294-6160 and press prompt #2.

New Survey Shows Remote Work Has Fueled Increased Drug Use

Retrieved on: 
Wednesday, August 31, 2022
Drug overdose, CEO, Female, Tobacco, Solution, MAT, Death, Awareness, Randomized controlled trial, Male, Method, Quit, Evidence-based practice, Confidentiality, Opioid use disorder, GLOBE, Workplace, Privacy, Opioid, Pharmacy, Opioid addiction treatment in United States prisons, Health insurance, Drug, Pharmaceutical industry

The survey of 1,000+ American workers was conducted by Quit Genius , which has launched the nations first digital clinic for opioid addiction.

Key Points: 
  • The survey of 1,000+ American workers was conducted by Quit Genius , which has launched the nations first digital clinic for opioid addiction.
  • The survey, conducted in July 2022, explored remote work, drug and alcohol use, and barriers to access to employer-provided addiction treatment programs.
  • Male remote workers were 1.4 times more likely than female remote workers to report being impaired by drugs and/or alcohol at work.
  • Similarly, 20 percent of respondents - 1 in 5 - said that drug and/or alcohol use has impacted their work performance.

Bicycle Health and Evernorth Team Up to Expand Access to Virtual Opioid Use Disorder Treatment

Retrieved on: 
Thursday, August 25, 2022
Office of Inspector General, U.S. Department of Health and Human Services, OIG, CEO, Program, Opioid use disorder, MAT, Conditional sentence, GLOBE, Leadership, News, OUD, HHS, History of the Office of the Inspector General of the United States Army, Patient, Buprenorphine/naloxone, Â, Health insurance, Cigna

Bicycle Healths virtual care model dramatically increases access to OUD treatment which is largely inaccessible in an in-person setting.

Key Points: 
  • Bicycle Healths virtual care model dramatically increases access to OUD treatment which is largely inaccessible in an in-person setting.
  • ( source )
    Through Bicycle Health, customers will have access to behavioral health clinicians who can help develop a personalized care plan, including a prescription to Buprenorphine/Naloxone (Suboxone), if appropriate.
  • Opioid use disorder is highly stigmatized in the US, which directly contributes to 90 percent of people with the disorder not pursuing treatment, said Ankit Gupta, CEO and founder of Bicycle Health.
  • Bicycle Health offers confidential evidence-based virtual care for opioid use disorder , from the comfort of your home.

Fentanyl Drives Fatal Overdoses to Over 107,000 Annually in the U.S. - Healthcare Providers' Effort to Fight Back

Retrieved on: 
Wednesday, August 24, 2022
Fentanyl, Homelessness, Research, Opioid use disorder, Drug, MAT, Risk assessment, Society, Sexual abuse, ASAM, Shame, Health, Asthma, Pain management, Prescription, Oregon Health Authority, Quality of life, Organization, Center, Transitive dependency, GLOBE, Patient, Hypertension, Substance use disorder, SUD, Stigma, Pharmacy, Korea Disease Control and Prevention Agency, Addiction medicine, Oregon Health Plan, McWilliams, Risk, Diabetes, American Society of Addiction Medicine, Naloxone, CDC, Pharmaceutical industry, Risk management, Equinox

American Society of Addiction Medicine (ASAM) encourages the co-prescribing of naloxone for people at risk of overdose , including those diagnosed with and being treated for opioid use disorder.

Key Points: 
  • American Society of Addiction Medicine (ASAM) encourages the co-prescribing of naloxone for people at risk of overdose , including those diagnosed with and being treated for opioid use disorder.
  • "If they say yes, 95% of them will say someone has given them naloxone."
  • Often, the drugs being consumed are a mixture of a variety of illicit substances, including fentanyl.
  • "Unfortunately, in the past there has been the misconception that naloxone was a medication that enabled drug abuse.

Empire BlueCross BlueShield Announces Four New Partnerships to Address Behavioral Healthcare Needs in New York

Retrieved on: 
Tuesday, August 23, 2022
Other Consumer, Women, Other Health, Teens, Men, Children, Telemedicine, Virtual Medicine, Insurance, Mental Health, Family, Consumer, Professional Services, Practice Management, LGBTQ+, Managed Care, General Health, Health, Health Insurance, Clifford Whittingham Beers, Partnership, Blue Cross Blue Shield Association, Medicaid, CEO, Opioid use disorder, Addiction medicine, ERP, Commercial, MAT, MBE, Insurance, Blue Shield, LinkedIn, Psychiatry, MD, Credentialing, Response, OCD, Twitter, Language, Tic disorder, OUD, Geography, Empire HealthChoice Assurance, Inc. v. McVeigh, Patient, Region, Hospital, Health insurance, Medicine, Pharmaceutical industry, Health, Headway, New Yorkers, Medicare

Today, Empire BlueCross BlueShield (Empire) is announcing a suite of innovative companies that are joining the Empire provider network as the company works to respond to the growing needs for behavioral healthcare services in New York.

Key Points: 
  • Today, Empire BlueCross BlueShield (Empire) is announcing a suite of innovative companies that are joining the Empire provider network as the company works to respond to the growing needs for behavioral healthcare services in New York.
  • Were excited to be entering a partnership with Empire BlueCross BlueShield to increase access to diverse, equitable, and affordable mental healthcare for New Yorkers, said Harry Ritter, founder and CEO, Alma.
  • Since launching with Empire in June 2022, more than 5,300 Empire members have received mental healthcare through Headway, with the average time to care just 5.9 days.
  • Serving New Yorkers for more than 85 years, Empire BlueCross BlueShield (Empire) is on a mission to materially and measurably improve the health of New Yorkers.

Greenhouse Treatment Center Designated as a Blue Distinction® Center for Substance Use Treatment and Recovery

Retrieved on: 
Monday, August 22, 2022
Patient safety, Research, CEO, Program, Accreditation, Knee, MAT, Blue, Substance, Addiction, Center, GLOBE, BDC, Opioid, Korea Disease Control and Prevention Agency, Transplant, Bariatric surgery, Greenhouse, Patient, Hospital, Residential care

GRAND PRAIRIE, Texas, Aug. 22, 2022 (GLOBE NEWSWIRE) -- To help patients suffering from a substance use disorder find facilities that deliver quality treatment and care, BCBSTX recognizes Greenhouse Treatment Center as one of the first facilities to receive the Blue Distinction Center for Substance Use Treatment and Recovery (BDC Substance Use Treatment and Recovery) designation a new designation under the Blue Distinction Specialty Care program.

Key Points: 
  • GRAND PRAIRIE, Texas, Aug. 22, 2022 (GLOBE NEWSWIRE) -- To help patients suffering from a substance use disorder find facilities that deliver quality treatment and care, BCBSTX recognizes Greenhouse Treatment Center as one of the first facilities to receive the Blue Distinction Center for Substance Use Treatment and Recovery (BDC Substance Use Treatment and Recovery) designation a new designation under the Blue Distinction Specialty Care program.
  • The BDC Substance Use Treatment and Recovery program requires designated facilities to deliver coordinated multidisciplinary care to patients and provide timely access to quality medical and psychosocial care in all phases of treatment.
  • Designated facilities must also offer medication-assisted treatment (MAT) a way to treat opioid addiction that includes a medication component and behavioral therapy.
  • Being one of the first addiction treatment facilities to receive such a prestigious designation is an immense honor, said Tyler Harrell, CEO of Greenhouse Treatment Center.

Ophelia Appoints Lon Binder as Chief Technology Officer to Increase Investment in Technology

Retrieved on: 
Monday, August 22, 2022
Medicaid, Health equity, CEO, Technology, Opioid use disorder, Addiction medicine, Commercial, MAT, Chief technology officer, Heart, Culture, Warby Parker, Centers for Medicare & Medicaid Services, Organization, Creativity, NEW, Psychiatry, FDA, Internet, Optometry, Knowledge, OUD, CTO, Growth, Patient, Pharmaceutical industry, Medicare, City block

NEW YORK, Aug. 22, 2022 /PRNewswire/ -- Ophelia, digital provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), today announced the expansion of both its executive team and technological capabilities with the appointment of Chief Technology Officer (CTO), Lon Binder. Former CTO of Cityblock Health, Binder brings a wealth of knowledge and in-depth experience in health equity and technology to Ophelia, to enhance both the patient and clinical experiences that Ophelia provides.

Key Points: 
  • Former CTO of Cityblock Health, Binder brings a wealth of knowledge and in-depth experience in health equity and technology to Ophelia, to enhance both the patient and clinical experiences that Ophelia provides.
  • As CTO, Binder will also manage a team of product designers and engineers who will support this work and further technological growth for Ophelia.
  • "Lon is an experienced technology leader with a rare combination of vision, creativity, heart, and drive."
  • Binder brings robust experience across technology and health equity spaces to his new role at Ophelia.

Bicycle Health and Tele911 Partner to Bring OUD Care to Emergency Patients

Retrieved on: 
Tuesday, August 16, 2022
CEO, GLOBE, Addiction, Telehealth, Substance abuse, MAT, EMS, Patient, SAN, OUD, Opioid, Partnership, ERS, Medication, Opioid use disorder, Organization, Health insurance

A Tele911 Licensed Social Worker will refer the patient to Bicycle Health for continued support and care.

Key Points: 
  • A Tele911 Licensed Social Worker will refer the patient to Bicycle Health for continued support and care.
  • Onboarding patients in emergency situations through the partnership with Tele911 will ensure that even the most vulnerable populations can discover and access Bicycle Health, helping to close the treatment gap when they need it most.
  • Compared to traditional in-person care, Bicycle Healths model yields increased retention numbers, meaning 86% of insured patients are still in treatment after 30 days.
  • About Bicycle Health: Bicycle Heath is a remote-first digital health start-up that offers online Medication for Addiction Treatment (MAT) for individuals with Opioid Use Disorder.